NSN - 6505-01-156-2044, 6505011562044 of Loxapine Capsules U
Aviation Axis stocks NDC00378-7025-01, NDC00591-0371-01 - Loxapine Capsules U made by Mylan Pharmaceuticals Inc, Watson Pharmaceuticals Inc with 6505-01-156-2044. Owned and operated by ASAP Semiconductor, we have access to over 2 billion new and after-market parts applicable within the aerospace and defense industries. All our parts are shipped using our premier shipping and supply chain. We offer short lead-times and some of the fastest shipping times in the industry. We are well-equipped to handle any customer situation - including AOG. Submit an RFQ today and expect a response within 15 minutes or less. ASAP - the evolution of purchasing.
Alternative NSN: 6505-01-156-2044 |
Item Name: Loxapine Capsules U |
NIIN: 011562044 |
NCB Code: USA (01) |
Manufacturers: Mylan Pharmaceuticals Inc, Watson Pharmaceuticals Inc |
Part No | Manufacturer | Item Name | QTY | RFQ |
---|---|---|---|---|
NDC00378-7025-01 | mylan pharmaceuticals inc | loxapine capsules u | Avl | RFQ |
NDC00591-0371-01 | watson pharmaceuticals inc | loxapine capsules u | Avl | RFQ |
Technical Characteristics of NSN 6505011562044
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS LOXAPINE SUCCINATE EQUIVALENT |
AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | LOXAPINE CAPSULES USP 25MG 100S BT |
CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
Related NSN List for 6505-01-156-2044, 6505011562044
Send Instant RFQ